FAIRFIELD, N.J., May 4, 2012 /PRNewswire/ -- Aperture Health, Inc. (OTC APRE) is focusing in on rapidly capitalizing on its newly formed relationship with Reliable Medical by growing its market share and awareness in the tri-state area, and by attracting available acquisition targets from this higher valued, but fragmented, sector for home IV companies which tend to be substantially smaller than those in specialty pharmacy and institutional Rx. A high service component generally provides for both substantially higher margins and high barriers to entry from competitors. Accordingly, compared to the other segments in pharmacy services, home IV is arguably far less risky and is valued highly by bottom line vs. top line focused buyers. Recent reports from industry experts name 16 M&A transactions completed in 2011, where home IV posted its highest transaction volume since 2008. Equally important, the 16 deals were spread among many different buyers – a breadth of activity from an active M&A environment stimulates competition and enhances value of all home IV companies.
James Hennig, R.Ph, Chief Executive Officer and Chairman of the Board of Directors commented, "We are extremely excited about the highly valued home IV sector and the prospects for our home IV business operated through our wholly owned subsidiary Triad Therapeutics, Inc. One of our strategies in becoming a publicly traded company was to have greater access to capital and a viable currency to do selective and accretive acquisitions to enhance our top line revenues and bottom line profitability."
About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad Therapeutics operates a fully JCAHO accredited home IV therapy company, achieving this "gold standard" status in 2007. The company has built a well respected reputation in its industry for its therapy expertise and commitment to care for its patient clients. The company services clients throughout the States of New Jersey, New York and Connecticut, providing opportunity for organic growth. Triad's full time marketing and sales personnel continuously represent the company in the core services areas, growing and maintaining the company's referral source base. Patient referrals are made from physicians, hospitals, insurance companies, veterinarians and hospice care providers that have established a professional rapport with Triad.
Certain statements in this news release are forward-looking, including (without limitation) growing revenues and earnings, expected results from current projects and attracting new business. Undue reliance should not be placed on such forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties and other unpredictable factors, many of which are beyond the Company's control. The Company's actual results, performance and trends could differ materially from those indicated or implied by such statements as a result of various factors, including (without limitation) the continued strengthening of Triad's selling and marketing functions, continued customer satisfaction, contract renewal, new product development, continued availability of capable dedicated personnel, continued cost management, success and availability of acquisitions, availability of financing and other factors, as well as by factors applicable to most companies such as general economic, competitive and other business and civil conditions. Information regarding certain of those and other risk factors and cautionary statements that could affect future results, performance or trends is discussed in the Company's OTC Disclosure Statement and unaudited management financials posted on www.pinksheets.com . All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.
|SOURCE Aperture Health, Inc.|
Copyright©2010 PR Newswire.
All rights reserved